Pathway Genomics Corporation Obtains FDA Registration
SAN DIEGO--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has classified and registered Pathway Genomics’ proprietary saliva collection kit as a Class I exempt device. With guidance from licensed health care providers, Pathway’s saliva collection kit is used to collect samples from patients for genetic testing purposes.